SAGE
Sage Therapeutics
SAGE
SAGE
Delisted
SAGE was delisted on the 30th of July, 2025.
250 hedge funds and large institutions have $7.65B invested in Sage Therapeutics in 2018 Q1 according to their latest regulatory filings, with 56 funds opening new positions, 104 increasing their positions, 67 reducing their positions, and 28 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
more call options, than puts
Call options by funds: $ | Put options by funds: $
12% more funds holding
Funds holding: 224 → 250 (+26)
7% more capital invested
Capital invested by funds: $7.19B → $7.65B (+$468M)
3.43% less ownership
Funds ownership: 107.36% → 103.93% (-3.4%)
Holders
250
Holding in Top 10
12
Calls
$62.1M
Puts
$52.6M
Top Buyers
| 1 | +$136M | |
| 2 | +$101M | |
| 3 | +$66.1M | |
| 4 |
BlackRock
New York
|
+$53.2M |
| 5 |
American Century Companies
Kansas City,
Missouri
|
+$47.2M |
Top Sellers
| 1 | -$82.2M | |
| 2 | -$42.4M | |
| 3 | -$32.9M | |
| 4 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
-$32.8M |
| 5 |
Barclays
London,
United Kingdom
|
-$31.3M |